Search research articles
Contact Us
Filters
Showing results (41-50 of 75) with videos related to
Page
of 8
Sort By:
The Lancet. Psychiatry
|
February 16, 2019
The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data
Adam Al-Diwani, Adam Handel, Leigh Townsend, et al.
Brain : a Journal of Neurology
|
October 9, 2019
Glycine receptor autoantibodies disrupt inhibitory neurotransmission
Sarah J Crisp, Christine L Dixon, Leslie Jacobson, et al.
Neuromuscular Disorders : NMD
|
April 16, 2024
Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis
Katherine C Dodd, Rohan Ahmed, Philip Ambrose, et al.
BMJ Neurology Open
|
March 5, 2025
Clinical data and reporting quality in NMDAR-antibody encephalitis and pregnancy: a systematic review
Scarlett L Harris, Sophie N M Binks, Donal Skelly, et al.
Annals of Neurology
|
February 7, 2018
N-methyl-D-aspartate receptor antibody production from germinal center reactions: Therapeutic implications
Mateusz Makuch, Robert Wilson, Adam Al-Diwani, et al.
The New England Journal of Medicine
|
April 9, 2025
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
Richard J Nowak, Michael Benatar, Emma Ciafaloni, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 6, 2014
Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features
Michael Absoud, Ming J Lim, Richard Appleton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 21, 2014
Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK
Liene Elsone, Joanna Kitley, Sebastian Luppe, et al.
Journal of Neurology
|
October 11, 2025
Self-administration of rozanolixizumab via manual push and infusion pump methods in patients with generalised myasthenia gravis: a randomised, phase 3, open-label, crossover study
Vera Bril, Carlo Antozzi, Tomasz Berkowicz, et al.
Journal of Neuroimmunology
|
February 4, 2018
Thymoma-associated myasthenia gravis and LGI1-encephalitis, with nephrotic syndrome post-thymectomy
Jyh Yung Hor, Thien Thien Lim, Mei Chih Cheng, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 75) with videos related to
Sort By:
Page
of 8
The Lancet. Psychiatry
|
February 16, 2019
The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data
Adam Al-Diwani, Adam Handel, Leigh Townsend, et al.
Brain : a Journal of Neurology
|
October 9, 2019
Glycine receptor autoantibodies disrupt inhibitory neurotransmission
Sarah J Crisp, Christine L Dixon, Leslie Jacobson, et al.
Neuromuscular Disorders : NMD
|
April 16, 2024
Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis
Katherine C Dodd, Rohan Ahmed, Philip Ambrose, et al.
BMJ Neurology Open
|
March 5, 2025
Clinical data and reporting quality in NMDAR-antibody encephalitis and pregnancy: a systematic review
Scarlett L Harris, Sophie N M Binks, Donal Skelly, et al.
Annals of Neurology
|
February 7, 2018
N-methyl-D-aspartate receptor antibody production from germinal center reactions: Therapeutic implications
Mateusz Makuch, Robert Wilson, Adam Al-Diwani, et al.
The New England Journal of Medicine
|
April 9, 2025
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
Richard J Nowak, Michael Benatar, Emma Ciafaloni, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 6, 2014
Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features
Michael Absoud, Ming J Lim, Richard Appleton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 21, 2014
Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK
Liene Elsone, Joanna Kitley, Sebastian Luppe, et al.
Journal of Neurology
|
October 11, 2025
Self-administration of rozanolixizumab via manual push and infusion pump methods in patients with generalised myasthenia gravis: a randomised, phase 3, open-label, crossover study
Vera Bril, Carlo Antozzi, Tomasz Berkowicz, et al.
Journal of Neuroimmunology
|
February 4, 2018
Thymoma-associated myasthenia gravis and LGI1-encephalitis, with nephrotic syndrome post-thymectomy
Jyh Yung Hor, Thien Thien Lim, Mei Chih Cheng, et al.
Page
of 8